Moreover, the Smoothened (Smo) inhibitors of the Hedgehog (HH) pathway are activated in lung cancers and IGFBP-6 is differentially expressed in human normal-malignant lung tissue arrays [77,78]. Here, SMO is linked to lung cancer.